Satsuma Pharmaceuticals and SNBL Announce Four Abstracts to be Presented at the American Headache Society’s 67th Annual Scientific Meeting
Breaking Down the Future of Migraine Treatment: What the Latest Research Reveals As a seasoned medical journalist, I’ve spent years tracking the evolving landscape of migraine treatment. Recent announcements from Satsuma Pharmaceuticals and Shin Nippon Biomedical Laboratories, presented at the American Headache Society (AHS) 67th Annual Scientific Meeting, highlight a pivotal moment. We’re not just … Read more